Moody National Bank Trust Division’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,432
Closed -$212K 621
2023
Q3
$212K Buy
1,432
+29
+2% +$5.24K 0.01% 564
2023
Q2
$307K Hold
1,403
0.02% 504
2023
Q1
$307K Hold
1,403
0.03% 505
2022
Q4
$292K Hold
1,403
0.03% 494
2022
Q3
$306K Hold
1,403
0.03% 457
2022
Q2
$294K Buy
+1,403
New +$299K 0.03% 415
2019
Q2
Sell
-37
Closed -$4K 843
2019
Q1
$4K Sell
37
-88
-70% -$9.08K ﹤0.01% 1076
2018
Q4
$14K Buy
+125
New +$13.4K ﹤0.01% 550

Other funds holding RMD

Moody National Bank Trust Division's RMD Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of ResMed (RMD) in Q4 2023, closing a stake of 1,432 shares — an estimated $212K sold.

Moody National Bank Trust Division first reported a position in RMD in Q4 2018 and held it in 8 quarters. The position peaked at $307K in Q1 2023. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Moody National Bank Trust Division reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 1,432 ResMed shares in Q4 2023, an estimated $212K.
  • Moody National Bank Trust Division first reported a position in ResMed in Q4 2018 and held it in 8 quarters.
  • Moody National Bank Trust Division's ResMed position peaked at $307K in Q1 2023.
  • 688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.